Premier Alternatives

Glyphic Biotechnologies

Berkeley, CA · Founded 2021 · Privately Held (backing)

Operator of a biotechnology platform intended to increase binding affinity and improve consistency to help create personalized, precision cancer vaccines for patients of all backgrounds. Glyphic Biotechnologies is based in Berkeley, CA and was founded in 2021. Its last reported valuation was $155 million in Sep 2025. It has raised $43.8 million.

Last reported valuation
$155.0M
Oct 2026
Priced at
—
Total raised
$43.8M
Last round
—

Glyphic Biotechnologies key facts

as of Oct 2026
  • Operator of a biotechnology platform intended to increase binding affinity and improve consistency to help create personalized, precision cancer vaccines for patients of all backgrounds.
  • Glyphic Biotechnologies is valued at approximately $155.0M as of Oct 2026 (last reported valuation).
  • It has raised $43.8M; the latest was Early Stage VC in Sep 2025.
  • Notable investors include Gaingels, Calm Ventures, Valor Equity Partners, SBXi, Johnson & Johnson Innovation - JLABS — 35 tracked in total.
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$155.0M

Glyphic Biotechnologies's last reported valuation, Sep 2025. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Glyphic Biotechnologies with a free account
  • ·The complete investor list: 35 names
  • ·Watch Glyphic Biotechnologies: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Glyphic Biotechnologies funding rounds

No rounds on record

No funding rounds for Glyphic Biotechnologies are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Glyphic Biotechnologies valuation

Glyphic Biotechnologies's last reported valuation was $155 million in Sep 2025. No priced round, secondary trade or fund mark has surfaced since.

Glyphic Biotechnologies investors

35 investors are on record for Glyphic Biotechnologies, including Gaingels, Calm Ventures, Valor Equity Partners and SBXi. By type, the record holds 11 venture capital firms and 1 family office.

About Glyphic Biotechnologies

Operator of a biotechnology platform intended to increase binding affinity and improve consistency to help create personalized, precision cancer vaccines for patients of all backgrounds. The company's platform focuses on developing a single-molecule, massively parallel, de novo next-generation protein sequencing platform, enabling scientists and researchers to develop novel therapeutics and diagnostics and ultimately understand human biology and disease.

Sector
Healthcare
HQ
Berkeley, CA, United States
Founded
2021
Employees
30
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.